Tempus AI, Inc.

NASDAQ:TEM

Medical - Healthcare Information Services

Healthcare
$63.62 -3.50%

-$1.77 today

Market cap
$11.28B
Beta
3.62
P/E (TTM)
-28.8
EPS (TTM)
-$1.69
52W Low $41.73High $104.32

Volume 5.35M

Average 6.17M

TEM EBITDA Margin

EBITDA as a percentage of revenue.

Tempus AI, Inc.NASDAQ: TEM

EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026

EBITDA Margin narrows to -13.8%

EBITDA Margin was -13.8% in Q3 FY2026, down 2.2 pp from a year earlier. On a trailing-twelve-month basis it was -7.2%, up 1.0 pp year over year. Over 3 fiscal years it widened by 64.5 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 15 analysts of 8.7% for the fiscal year ending Dec 2026, up from -9.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
-13.8%-25.6 pp QoQ
Last fiscal yearDec 2025
-9.3%+78.7 pp YoY
LTMSep 2026
-7.2%+1.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-2.2 pp+13.7 pp+15.9 pp
1 year+78.7 pp+18.0 pp-60.7 pp
3 years+64.5 pp+21.6 pp-42.9 pp
5 years+35.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-9.3%
Year-over-year change
+78.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How TEM compares with its peers on the latest reported figures

  • TEM's LTM Sep 2026 EBITDA Margin of -7.2% is the 7th highest of the 11 companies compared; the peer median is -2.5%.
  • Its year-over-year change of +1.0 pp is the 6th highest of 11, against a peer median of +2.0 pp.
  • Over three fiscal years its change of +64.5 pp compares with a peer median of +32.4 pp.
TEM Competitors Peer median
EBITDA Margin for TEM and competitors
Company Period LTM level YoY 3-year change
QGENQiagen N.V.LTM Jun 202633.5% -1.6 pp-2.1 pp
ILMNIllumina, Inc.LTM Jun 202630.3% -11.3 pp+119.0 pp
DGXQuest Diagnostics IncorporatedLTM Sep 202619.4% -0.3 pp+1.5 pp
BLLNBillionToOne, Inc.LTM Jun 202612.6% +21.8 pp—
NEONeoGenomics, Inc.LTM Jun 20261.7% +5.8 pp+10.8 pp
NTRANatera, Inc.LTM Jun 2026-6.6% +4.2 pp+53.9 pp
TEMTempus AI, Inc.LTM Sep 2026-7.2% +1.0 pp+64.5 pp
BDSXBiodesix, Inc.LTM Mar 2026-19.1% +17.8 pp+110.1 pp
GHGuardant Health, Inc.LTM Sep 2026-34.5% +4.7 pp+98.7 pp
MYGNMyriad Genetics, Inc.LTM Mar 2026-40.3% -32.6 pp-27.6 pp
PSNLPersonalis, Inc.LTM Mar 2026-132.6% -47.0 pp—
Peer median (excluding TEM) -2.5%+2.0 pp+32.4 pp

Competitors are the stored peer set for TEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue257.85M320.67M531.82M693.4M1.27B
Cost of Revenue174.21M190.48M245.65M312.29M473.89M
Gross Profit83.64M130.19M286.18M381.11M797.9M
Gross Margin32.4%40.6%53.8%55.0%62.7%
Research & Development128.35M162.25M185.5M316.84M319.03M
Selling, General & Admin199M233.38M296.76M755.35M715.43M
Operating Expenses327.36M395.63M482.26M1.07B1.05B
Depreciation & Amortization23.88M30.41M33.33M37.25M102.32M
EBITDA(219.52M)(236.85M)(133.33M)(610.42M)(118.51M)
EBITDA Margin-85.1%-73.9%-25.1%-88.0%-9.3%
Operating Income(243.71M)(265.44M)(196.08M)(691.08M)(252.87M)
Operating Margin-94.5%-82.8%-36.9%-99.7%-19.9%
Interest Income623K3.03M7.6M11.08M12.63M
Interest Expense15.18M21.89M46.87M53.65M70.27M
Other Income / Expenses(15.48M)(24.3M)(17.75M)(14.46M)(43.84M)
Income Before Tax(259.19M)(289.75M)(213.83M)(705.54M)(296.71M)
Pre-Tax Margin-100.5%-90.4%-40.2%-101.8%-23.3%
Income Tax Expense066K288K266K(51.68M)
Net Income(259.19M)(289.81M)(214.12M)(705.81M)(245.03M)
Net Margin-100.5%-90.4%-40.3%-101.8%-19.3%
EPS (Basic)(1.75)(1.97)(1.73)(4.60)(1.41)
EPS (Diluted)(1.75)(1.97)(1.73)(4.60)(1.41)
Weighted Avg Shares169.88M169.88M154.17M162.12M174.26M
Weighted Avg Shares (Diluted)169.88M169.88M154.17M162.12M174.26M

Tempus AI, Inc.

NASDAQ:TEM

Intrinsic Alpha fair value

Locked

Current Price

$63.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.